Gut bacteria tested as potential treatment for common liver condition
NCT ID NCT07378280
Summary
This study tested whether a specific probiotic bacteria, called L. lactis CKDB001, could improve liver health in people with non-alcoholic fatty liver disease (NAFLD). 95 adults with elevated liver enzymes took either the probiotic or a placebo daily for 12 weeks. Researchers measured changes in liver function, blood sugar, cholesterol, inflammation, and gut bacteria to see if the probiotic was safe and effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hallym University Chuncheon Sacred Heart Hospital
Chuncheon, Gangwon-do, 24210, South Korea
Conditions
Explore the condition pages connected to this study.